We are live on ! Find out more
WVP

Worth Venture Partners Portfolio holdings

AUM $31.6M
1-Year Est. Return 28.5%
This Fund
S&P 500
This Quarter Est. Return
+22.16%
1 Year Est. Return
+28.5%
3 Year Est. Return
+102.5%
5 Year Est. Return
+128.77%
10 Year Est. Return
AUM
$204M
AUM Growth
+$41.2M
Cap. Flow
+$34M
Cap. Flow %
16.72%
Top 10 Hldgs %
64.81%
Holding
152
New
50
Increased
18
Reduced
29
Closed
35

Sector Composition

Rank Sector Weight
1 Technology 11.48%
2 Healthcare 6.98%
3 Consumer Discretionary 2.55%
4 Consumer Staples 1.24%
5 Real Estate 1.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BFX
1
DELISTED
BowFlex Inc.
BFX
$3.41M 1.67%
367,391
-252,953
-41% -$1.53M
CCL icon
2
PUT
Carnival Corporation Ltd
CCL
$36.1B
$2.96M 1.45%
+548,700
New +$8.22M
MTSI icon
3
MACOM Technology Solutions
MTSI
$20.4B
$2.7M 1.33%
+78,540
New +$2.29M
OBCI
4
DELISTED
Ocean Bio-Chem Inc
OBCI
$2.52M 1.24%
+180,681
New +$1.21M
COHR icon
5
Coherent
COHR
$55.2B
$2.41M 1.18%
+51,000
New +$2.02M
ATEX icon
6
CALL
Anterix
ATEX
$1.83B
$2.31M 1.13%
439,800
+321,100
+271% +$16.4M
MXL icon
7
MaxLinear
MXL
$6.41B
$2.29M 1.13%
+106,847
New +$1.84M
CYBE
8
DELISTED
Cyberoptics Corp
CYBE
$2.02M 0.99%
62,700
MRAM icon
9
Everspin Technologies
MRAM
$354M
$1.88M 0.92%
+267,586
New +$1.32M
SNCR
10
DELISTED
Synchronoss Technologies
SNCR
$1.66M 0.82%
52,348
AIRG icon
11
Airgain
AIRG
$74.3M
$1.66M 0.81%
154,222
+23,950
+18% +$204K
FLXN
12
DELISTED
Flexion Therapeutics, Inc.
FLXN
$1.34M 0.66%
+102,000
New +$1.06M
SILC icon
13
Silicom
SILC
$228M
$1.3M 0.64%
35,550
-8,011
-18% -$258K
SCPH
14
DELISTED
scPharmaceuticals
SCPH
$1.29M 0.63%
175,526
+31,880
+22% +$280K
IWM icon
15
iShares Russell 2000 ETF
IWM
$80.9B
$1.14M 0.56%
7,961
+572
+8% +$75.1K
APPS icon
16
Digital Turbine
APPS
$1.02B
$1.11M 0.55%
88,397
-108,330
-55% -$756K
ALLT icon
17
Allot
ALLT
$374M
$1.07M 0.52%
+101,867
New +$1.08M
MIRM icon
18
Mirum Pharmaceuticals
MIRM
$6.89B
$1.03M 0.51%
53,151
-761
-1% -$12.7K
CMRX
19
DELISTED
Chimerix, Inc.
CMRX
$1.03M 0.51%
+333,685
New +$864K
CLFD icon
20
Clearfield
CLFD
$421M
$1.01M 0.5%
72,550
-2,539
-3% -$32.9K
CPRX
21
DELISTED
Catalyst Pharmaceutical
CPRX
$983K 0.48%
212,950
-21,675
-9% -$97.4K
VUZI icon
22
Vuzix
VUZI
$190M
$885K 0.43%
+370,617
New +$767K
ATXS
23
DELISTED
Astria Therapeutics
ATXS
$883K 0.43%
22,904
-4,165
-15% -$148K
ASPN icon
24
Aspen Aerogels
ASPN
$387M
$819K 0.4%
124,487
-83,657
-40% -$537K
ALIM
25
DELISTED
Alimera Sciences
ALIM
$802K 0.39%
127,333

Similar funds

Worth Venture Partners's Q2 2020 Portfolio in Review

As of Q2 2020, Worth Venture Partners held 152 positions worth $204M, up 25% from $162M the previous quarter. Its ten largest holdings account for 65% of the portfolio.

Worth Venture Partners deployed $34M of net new capital in Q2 2020, opening 50 new positions and adding to 18 existing holdings. Its largest new stake was MACOM Technology Solutions: 78,540 shares worth $2.7M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 8% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was BowFlex Inc., an estimated $1.53M trimmed.

  • Worth Venture Partners's largest Q2 2020 buy was MACOM Technology Solutions: 78,540 shares worth $2.7M.
  • Worth Venture Partners added most to scPharmaceuticals in Q2 2020, an estimated $280K increase.
  • Worth Venture Partners's biggest Q2 2020 reduction was BowFlex Inc., cutting an estimated $1.53M.
  • Worth Venture Partners fully exited Dropbox in Q2 2020, selling an estimated $1.91M.
  • Worth Venture Partners's ten largest holdings make up 65% of its $204M portfolio in Q2 2020.
  • Worth Venture Partners opened 50 new positions and closed 35 in Q2 2020.
  • Worth Venture Partners's portfolio value rose 25% quarter-over-quarter to $204M.

Based on Worth Venture Partners's 13F filing for Q2 2020, filed 14 Aug 2020.